An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy
Clinical trial NCT05540964 · UNKNOWN
Trial details
- NCT number
- NCT05540964
- Sponsor
- American Gene Technologies International Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-19
- Primary completion
- 2025-07-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.